Effect of ramipril on the incidence of diabetes.

Effect of ramipril on the incidence of diabetes.

BACKGROUND: Previous studies have suggested that blockade of the renin-angiotensin system may prevent diabetes in people with cardiovascular disease or hypertension. METHODS: In a double-blind, randomized clinical trial with a 2-by-2 factorial design, we randomly assigned 5269 participants without...

Bibliográfalaš dieđut
Váldodahkkit:	Bosch, J, Yusuf, S, Gerstein, H, Pogue, J, Sheridan, P, Dagenais, G, Diaz, R, Avezum, A, Lanas, F, Probstfield, J, Fodor, G, Holman, R
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2006

Geahča maid

Incidence of diabetes following ramipril or rosiglitazone withdrawal
Dahkki: Holman, R, et al.
Almmustuhtton: (2011)

Incidence of diabetes following ramipril or rosiglitazone withdrawal.
Dahkki: Investigators, D
Almmustuhtton: (2011)

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.
Dahkki: Punthakee, Z, et al.
Almmustuhtton: (2012)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
Dahkki: Gerstein, H, et al.
Almmustuhtton: (2006)

A Comparative Evaluation of Ramipril as Monotherapy and Combination of Ramipril with Torsemide in Hypertension
Dahkki: Navjot Kaur, et al.
Almmustuhtton: (2017-11-01)

Trial update: the Diabetes REduction Approaches with ramipril and rosiglitazone Medications (DREAM) trial
Dahkki: G. Gulli
Almmustuhtton: (2013-05-01)

Ramipril induced pemphigoid vulgaris
Dahkki: Mirza MA, et al.
Almmustuhtton: (2018-09-01)

Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy
Dahkki: Daniele Bosone, et al.
Almmustuhtton: (2016-09-01)

Ramipril therapy in acute myocardial infarction
Dahkki: V. A. Lusov, et al.
Almmustuhtton: (2008-10-01)

Ramipril poisoning rescued by naloxone and terlipressin
Dahkki: Samanta Samanta, et al.
Almmustuhtton: (2014-01-01)

The Degradation Product of Ramipril Is Potentially Carcinogenic, Genotoxic and Mutagenic
Dahkki: Katarzyna Regulska, et al.
Almmustuhtton: (2023-02-01)

Effect of ramipril on renal function in patients with intermittent claudication
Dahkki: Simon D Hobbs, et al.
Almmustuhtton: (2008-04-01)

A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
Dahkki: Hertzel C. Gerstein, et al.
Almmustuhtton: (2022-08-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
Dahkki: I. V. Szirov, et al.
Almmustuhtton: (2015-12-01)

FIXED COMBINATION OF RAMIPRIL AND HYDROCHLOROTHIAZIDE: TO WHOM AND WHAT FOR?
Dahkki: S. V. Nedogoda
Almmustuhtton: (2016-09-01)

Development of Methods of Quality Control of the Tablets «Ramipril»
Dahkki: Kateryna Typlynska, et al.
Almmustuhtton: (2023-04-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
Dahkki: I. V. Szirov, et al.
Almmustuhtton: (2015-12-01)

V fokuse vnimaniya - ingibitoryangiotenzinprevrashchayushchegofermenta: ramipril priarterial'noy gipertonii
Dahkki: I E Chazova, et al.
Almmustuhtton: (2011-09-01)

Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
Almmustuhtton: (2008)

The place of ramipril in modern guidelines for the management of patients with cardiovascular diseases
Dahkki: E. E. Averin, et al.
Almmustuhtton: (2019-01-01)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
Dahkki: S. R. Willoughby, et al.
Almmustuhtton: (2015-12-01)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
Dahkki: S. R. Willoughby, et al.
Almmustuhtton: (2015-12-01)

Comparison of the efficacy, safety and tolerability of ramipril with amlodipine in treatment of mild to moderate hypertension in Nigerians
Dahkki: B J C Onwubere, et al.
Almmustuhtton: (2007-01-01)

MARRIAGE: A Randomized Trial of Moxonidine Ramipril or in Combination With Ramipril in Overweight Patients With Hypertension and Impaired Fasting Glucose or Diabetes Mellitus. Impact on Blood Pressure, Heart Rate and Metabolic Parameters
Dahkki: Paul Valensi MD, et al.
Almmustuhtton: (2024-06-01)

Three-dimensional printing of ramipril tablets by fused deposition modeling
Dahkki: O. A. Terenteva, et al.
Almmustuhtton: (2021-12-01)

Effect of Valsartan on the Incidence of Diabetes REPLY
Dahkki: Holman, R, et al.
Almmustuhtton: (2010)

Comparative effectiveness of fixed combinations of various ramipril and hydrochlorothiazide doses
Dahkki: I. E. Chazova, et al.
Almmustuhtton: (2010-08-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
Dahkki: V. I. Podzolkov, et al.
Almmustuhtton: (2015-09-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
Dahkki: V. I. Podzolkov, et al.
Almmustuhtton: (2015-09-01)

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored.
Dahkki: McMurray, J, et al.
Almmustuhtton: (2014)

Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL Study (Diabete, Ipertensione, Albuminuria, Lercanidipina)
Dahkki: M. Dalla Vestra, et al.
Almmustuhtton: (1970-01-01)

RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
Dahkki: A. I. Chesnikova, et al.
Almmustuhtton: (2016-01-01)

Solid-State Stability Profiling of Ramipril to Optimize Its Quality Efficiency and Safety
Dahkki: Katarzyna Regulska, et al.
Almmustuhtton: (2021-10-01)

ESTIMATION OF NEPHROPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME RAMIPRIL IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
Dahkki: M.A. Dolinnayä, et al.
Almmustuhtton: (2017-03-01)

CHANGES IN CLINICAL MANIFESTATION OF CONGESTIVE HEART FAILURE AT THE BACKGROUND OF REGULAR RAMIPRIL INTAKE
Dahkki: A. G. Kuzmin, et al.
Almmustuhtton: (2014-08-01)

Efficiency (advantages) of ramipril in arterial hypertension and diabetes mellitus from the point of view of evidence-based medicine
Dahkki: M. V. Leonova
Almmustuhtton: (2020-05-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
Dahkki: D. A. Napalkov, et al.
Almmustuhtton: (2016-01-01)

DISSOLUTION PROFILE STUDIES FOR RAMIPRIL AND LERCANIDIPINE FIXED-DOSE COMBINATION
Dahkki: A. A. Shadrin, et al.
Almmustuhtton: (2019-01-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
Dahkki: Duygun Altıntaş Aykan, et al.
Almmustuhtton: (2020-10-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
Dahkki: D. A. Napalkov, et al.
Almmustuhtton: (2016-01-01)